Cite
MLA Citation
G N Hortobagyi et al.. “Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.” Annals of oncology, vol. 29, 2018, pp. 1541–1547. http://access.bl.uk/ark:/81055/vdc_100095485582.0x000038